The history of MF59 ® adjuvant: a phoenix that arose from the ashes
Year: 2012
Type: review
Source: Expert Review of Vaccines
DOI: 10.1586/erv.12.140
Institutions: Dynavax Technologies (United States), Novartis (Italy)
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2156580403
